Predefined and inductively defined categories of analysis
| Category | Definition |
| Subtask 1: Assessing eligibility for medical abortion | |
| Eligibility assessment | Any assessment of self-controlled methods of determining eligibility |
| Subtask 2: Administering the medications and managing the process and common side-effects | |
| Information and counselling | Provision or receipt of information from non-provider sources, such as pamphlets, hotlines or websites (lay sources of information) about how to procure and administer MA |
| Feasibility | Feasibility of administration of all or part of an MA regimen by an individual at home or elsewhere outside of a health facility |
| Safety and efficacy | Clinical outcomes (including completion and complications) related to administration of MA by an individual at home |
| Management of side effects and complications | Self-management of pain, bleeding, expulsion of the products of conception and self-identification of the need to seek formal healthcare for potential complications |
| Sources of medicine | |
| Pharmacy provision | Documentation of sourcing of MA from pharmacists or pharmacies |
| Facility | Documentation of sourcing of MA from a health worker in a health facility |
| Online provision and telemedicine | Provision or acquisition of MA pills and/or information about the process via website or via telemedicine, that is, providers using telecommunications technology to interact with patients remotely |
| Location of drug administration | |
| Home and facility | Administration of part of the regimen at home and part of the regimen at a health facility |
| Home only | Administration the entire drug regimen at home |
| Subtask 3: Assessing completion of the process and the need for further clinic-based follow-up | |
| Approaches to self-assessment of completion | Approaches to determining completion of process, such as checklists, β-hCG, other technologies |
| Post-MA contraception | Self-led take up, safety and acceptability of contraceptive methods after MA |
| Failure and adverse events related to self-use | Prevalence and characteristics of adverse events, including the need for surgical intervention, hospital admission, blood transfusion, emergency department treatment, intravenous antibiotics administration, infection and death, as follow-on events from cases of self-administration of combined regimen and/or misoprostol-only induced abortions |
| Other | |
| Knowledge, attitudes and practices | Measure of awareness and opinions regarding MA self-use among partners, providers and relevant others |
| Preferences and experiences with self-use | Measure of preferences regarding self-use of MA from people taking the drugs |
| Cost-effectiveness | Documentation of the degree to which a specific aspect of MA self-use is good value for the resources required |
| Prevalence | Documentation of measurement of the number of cases experiencing a specific aspect of MA self-use in a particular population at a given time |
MA, medical abortion.